Citigroup’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
9,840
+8,286
| +533% | +$92.9K | ﹤0.01% | 3631 |
|
|
2025
Q1 | $15.9K | Sell |
1,554
-6,474
| -81% | -$66.4K | ﹤0.01% | 4354 |
|
|
2024
Q4 | $156K | Sell |
8,028
-18,692
| -70% | -$362K | ﹤0.01% | 3742 |
|
|
2024
Q3 | $655K | Buy |
+26,720
| New | +$655K | ﹤0.01% | 2827 |
|
|
2022
Q2 | – | Sell |
-149
| Closed | -$4K | – | 5785 |
|
|
2022
Q1 | $4K | Buy |
+149
| New | +$4K | ﹤0.01% | 5097 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5316 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$1K | – | 5634 |
|
|
2015
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5290 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5570 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$1K | – | 5691 |
|
|
2014
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5358 |
|
|
2014
Q3 | – | Sell |
-2
| Closed | -$4K | – | 5622 |
|
|
2014
Q2 | $4K | Buy |
+2
| New | +$4K | ﹤0.01% | 4923 |
|
|
2013
Q3 | – | Sell |
-3
| Closed | -$6K | – | 5316 |
|
|
2013
Q2 | $6K | Buy |
+3
| New | +$6K | ﹤0.01% | 4635 |
|